Specialty Pharmacy

Several drugs are in the pipeline for the treatment of specialty conditions, including cancer and multiple sclerosis.

The investigational regimen may be appropriate for a broad range of HIV-positive patients.

Reducing the cost of antiretroviral therapy could produce even more savings in the treatment of HIV.

Top news of the day from across the health care landscape.

Two different Copaxone injection doses approved for relapsing forms of multiple sclerosis.

Patients with chronic kidney disease are at risk for several comorbid conditions, including cardiovascular disease.

Cancer patient Beth Wallace speaks about her support system and the impact they have made on her life.

The fate of the 340B program is unclear amid several proposals to make changes.

The pharma giant will now focus on its PD-1 cancer immunotherapy Keytruda.

Ramping up programs for injection drug users is a key part in preventing transmission of hepatitis C.

Top news of the day from across the health care landscape.

The neurodegenerative phase of multiple sclerosis remains a significant challenge for researchers.

Women in Specialty Pharmacy Lunch brings together leaders from various aspects of the specialty landscape.

Beth Wallace discusses various treatments for leiomyosarcoma, including doxorubicin (Adriamycin), nicknamed the red devil.

Payer requirements for outcomes data are becoming more stringent.

Testing and treatment programs should focus on populations driving new cases of hepatitis C virus.

Outcomes and accreditation measures are among the key factors in building a successful specialty pharmacy, according to a session at the annual NASP meeting.

Becoming an accredited specialty pharmacy requires a large time investment and a significant commitment to properly record and report specific data.

Nearly 80% of Americans said they would follow their pharmacist on social media.

Top news of the day from across the health care landscape.

Gadolinium-containing imaging agent could improve breast cancer survival.

Recent studies suggested that hepatitis C antiviral drugs may increase the risk of hepatocellular carcinoma.

The Drug Quality and Security Act provides a foundation for improving the safety of drug compounding by working with outsourcing facilities to meet regulatory standards.

In part 2, Beth Wallace describes the events leading up to her diagnosis with leiomyosarcoma.

Data from a phase 2 trial demonstrates positive results on improving the disabling symptoms of a rare form of autism.

Genentech is seeking approval for Perjeta used in combination with trastuzumab and chemotherapy for adjuvant treatment of HER2-positive early breast cancer.

Consolidative radiation followed by chemotherapy could play a key role in future survival outcomes among patients with non-small cell lung cancer.

Top news of the day from across the health care landscape.

New findings suggest alterations in this process may trigger cancer progression.

Top news of the week from Specialty Pharmacy Times.